Cryo-Cell International, Inc. (CCEL) financial statements and ratios from SEC XBRL: revenue $0.0B (TTM), net margin -7.7%, revenue growth -1.9% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (latest FY) | $31.57M |
| Revenue (TTM) | $0.0B |
| Net Margin | -7.7% |
| Operating Margin (TTM) | -0.3% |
| Net Debt / EBITDA | 8.9 |
| Revenue Growth (YoY) | -1.9% |
| EPS Growth (YoY) | 75.0% |
| FCF Growth (YoY) | 181.3% |
| EV / EBITDA | 49.2 |
| Price / Sales | 1.13 |
| FCF Yield | 17.4% |
| Altman Z-Score | -0.23 (distress) |
| Piotroski F-Score | 6/9 |
| Piotroski checks passed | 6 of 9 |
| Industry P/E (Healthcare Services) | 25.4 |
| Sector P/E (Healthcare) | 21.9 |
CCEL overview · CCEL earnings · CCEL KPIs · CCEL documents · CCEL ownership · CCEL peers
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.